Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 322 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Vancomycin hydrochloride Clear all

Conditions: Staphylococcal Skin Infection
Interventions: Telavancin, Vancomycin; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 862 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: National City, California

Conditions: Clostridium Difficile Infection Recurrence
Interventions: bezlotoxumab, Vancomycin Oral; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Parkinson Disease
Interventions: Fecal Microbiota Transplant; Combination Product
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Ventura, California

Conditions: Hematopoietic Stem Cell Transplantation, Vancomycin-Resistant Enterococci
Interventions: Theraworx™ bath wipes, Standard bath wipes; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Antibotics in Cementless Knees
Interventions: Tobramycin Powder, Vancomyscin; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Congenital Heart Diseases, Aortic Valve Disorder
Interventions: Cefazolin 25 mg/kg body weight and Vancomycin hydrochloride, Cefazolin 30 mg/kg body weight; Drug
Lead sponsor: Stanford University; Other
Eligibility: Up to 18 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Autism Spectrum Disorder, Autism
Interventions: Fecal Microbiota Transplant; Vancomycin; Biological
Lead sponsor: ProgenaBiome; Other
Eligibility: 2 Years and older
U.S. locations: 1
States / cities: Ventura, California

Conditions: Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium
Interventions: Vancomycin (POC); Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 65 Years to 100 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Glen Burnie, Maryland

Conditions: Antibiotic Prophylaxis
Interventions: cefazolin or vancomycin, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Total Knee Replacement
Interventions: hand mixed vancomycin, hand mixed tobramycin, pre-mixed tobramycin; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cellulitis, Skin Infections
Interventions: Daptomycin, Vancomycin; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Osteomyelitis, Methicillin-resistant Staphylococcus Aureus
Interventions: trimethoprim-sulfamethoxazole, vancomycin; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Osteomyelitis
Interventions: Intravenous Antibacterial Agent, Oral Antibacterial Agent; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Acute Kidney Injury
Interventions: Blood sample; Procedure
Lead sponsor: Avera McKennan Hospital & University Health Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Complicated Skin and Soft Tissue Infection
Interventions: Ceftaroline fosamil, Vancomycin, Aztreonam; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 10
States / cities: Chula Vista, California • Orlando, Florida • West Palm Beach, Florida + 7 more

Conditions: Acute Bacterial Skin and Skin Structure Infections
Interventions: Tedizolid phosphate, Comparator; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 1 Day to 11 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: San Diego, California • Chicago, Illinois • Detroit, Michigan + 5 more

Conditions: Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL), Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed
Interventions: Vancomycin 125mg, Radiation Therapy, CAR-T; Drug · Radiation · Biological
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Peritoneal Dialysis-associated Peritonitis
Interventions: Vancomycin; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gram-Positive Bacterial Infections
Interventions: Telavancin, Vancomycin, nafcillin, oxacillin, or cloxacillin; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Marietta, Georgia

Conditions: Clostridium Difficile Infection, Diarrhea
Interventions: Oral Vancomycin, Placebo, Toxin enzyme immunoassay, Nuceleic acid amplification test; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Sepsis
Interventions: personalized dosing adjustment of vancomycin; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Month to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Red Man Syndrome
Interventions: Not listed
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 6 Months to 21 Years
Enrollment: 544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: MRSA, Cystic Fibrosis
Interventions: Vancomycin inhalation powder, Placebo inhalation powder; Drug
Lead sponsor: Savara Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 69
States / cities: Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 62 more

Conditions: Healthy Volunteers
Interventions: VE303, Oral Vancomycin; Drug
Lead sponsor: Vedanta Biosciences, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci

Intraarticular Antibiotic in TKA

Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients

Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin

Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy

Antibiotic Elution in Total Knee Arthroplasty

Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis

Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis

Pharmacokinetics of Vancomycin in the ICU in Renal Replacement Therapy

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

Vancomycin Associated Red Man Syndrome (RMS)

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis

First-in-human Study of VE303 in Healthy Adult Volunteers